Papers of particular interest, published recently, have been highlighted as: • Of importance
1. Mettlin CJ, Murphy GP, Rosenthal DS, et al. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1679–84.
2. Mettlin CJ, Murphy GP, McDonald CJ, et al. The National Cancer Data Base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer. 1999;86:1877–82.
3. Shipley WU, Thames HD, Sandler HM, et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA. 1999;281:1598–604.
4. D’Amico AV, Chen MH, Renshaw AA, Loffredo B, Kantoff PW. Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy. J Clin Oncol. 2008;26:2979– 83.
5. Suzuki N, Shimbo M, Amiya Y, et al. Outcome of patients with localized prostate cancer treated by radiotherapy after confirming the absence of lymph node invasion. Jpn J Clin Oncol. 2010;40:652–7.
6. Touma NJ, Izawa JI, Chin JL. Current status of local salvage therapies following radiation failure for prostate cancer. J Urol. 2005;173:373–9.
7. Zietman AL, Bae K, Slater JD, et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/American College of radiology 95–09. J Clin Oncol. 2010;28:1106–11.
8. Crook JM, Perry GA, Robertson S, Esche BA. Routine biopsies following radiotherapy for prostate cancer: results for 226 patients. Urology. 1995;45:624–31.
9. Siddiqui SA, Mynderse LA, Zincke H, et al. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience. Urology. 2007;70:80–5.
10. Chin JL, Lim D, Abdelhady M. Review of primary and salvage cryoablation for prostate cancer. Cancer Control. 2007;14:231–7.
11. Finley DS, Pouliot F, Miller DR, Belldegrun AS. Primary and salvage cryotherapy for prostate cancer. Urol Clin North Am. 2010;37:67–82.
12. • Babaian RJ, Donnelly B, Bahn D, et al.: AUA Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol 2008. 180:1993–2004. This is the American Urological Association consensus statement on the cryosurgery, an evidence- based review of the literature with panel recommendations.
13. Nguyen PL, D'Amico AV, Lee AK, Suh WW. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer. 2007;110:1417–28.
14. Spiess PE, Lee AK, Leibovici D, et al. Presalvage prostate-specific antigen and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Cancer. 2006;107:275–80.
15. Vergunst H, Langenhuijsen JF. Rebuttal from Authors re: J. Stephen Jones. Ten Misconceptions regarding cryotherapy for prostate cancer. Eur Urol. 2009;55:52–5.
16. • Williams A, Martinez C., Chalasani V, Pautler SE, Chin JL. Long term results of salvage cryotherapy for prostate cancer. Presented at the 11th Annual Meeting of the Society of Urologic Oncology, Bethesda, Maryland; Dec 8–10, 2010. This is one of the largest salvage cryoablation series and longest series to date
17. Chin JL, Pautler SE, Mouraviev V, et al. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol. 2001;165:1937–42.
18. De la Taille A, Benson MC, Bagiella E, et al. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. BJU Int. 2000;85:281–6.
19. Izawa JI, Madsen LT, Scott SM, et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol. 2002;20:2664–71.
20. Pisters LL, Perrotte P, Scott SM, et al. Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy. J Clin Oncol. 1999;17:2514–20.
21. Spiess PE, Katz AE, Chin JL, et al. A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancer. BJU Int. 2009;106:194–8.
22. Bahn DK, Lee F, Silverman P, et al. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer. 2003;2:111–4.
23. Cheetham P, Truesdale M, Chaudhury S, et al. Long-term cancer- specific and overall survival for men followed more than 10 years after primary and salvage cryoablation of the prostate. J Endo. 2010;24:1123–9.
24. Huang WC, Kuroiwa K, Serio AM, et al. The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies. J Urol. 2007;177:1324–9.
25. Klossner DP, Baust JM, VanBuskirk RG, Gage AA, Baust JG. Cryoablative response of prostate cancer cells is influenced by androgen receptor expression. BJU Int. 2008;101:1310–6.
26. • Rastinehad A, Benjamin C, Chung P, et al.: Cancer detection rates on MR/Ultrasound fused image guided prostate biopsies directly correlates with multi-parametric MRI. Presented at the 11th Annual Meeting of the Society of Urologic Oncology, Bethesda, Maryland; Dec 8–10, 2010. This article provides one of several examples of rapidly improving biopsy technique using fusion of magnetic resonance and ultrasound.
27. Eisenberg ML, Shinohara K. Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Urology. 2008;72:1315–8.
28. • Abdelhady M, Abusamra A, Elmaadawi A, et al.: Health related quality of life (HRQOL) outcome after salvage cryosurgery of the prostate: comparison with outcome after primary radiotherapy. J Urol suppl 2007. 177:3. This is one of few HRQOL studies on salvage cryoablation using validated instruments.
29. Robinson JW, Donnelly BJ, Coupland K, et al. Quality of life 2 years after salvage cryosurgery for the treatment of local recurrence of prostate cancer after radiotherapy. Urol Oncol. 2006;24:472–86.
30. Perrotte P, Litwin M, McGuire EJ, et al. Quality of life after salvage cryotherapy: the impact of treatment parameters. J Urol. 1999;162:398–402.
31. Levy DA. Correlation of thermocouple data with voiding function after prostate cryoablation. Urology. 2010;75:482–7.
32. De la Taille A, Hayek O, Benson MC, et al. Salvage cryotherapy for recurrent prostate cancer after radiation treatment: the Columbia experience. Urology. 2000;55:79–84.
33. Long JP, Fallick ML, LaRock DR, Rand W. Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma. J Urol. 1998;159:477–84.
34. Yin L, Choi WW, Gu X, et al.: Complications of primary vs salvage cryotherapy for prostate cancer. Presented at the American Urologic Association Meeting. San Francisco, California; May 29-June 3, 2010, Abstract #1066.
35. Anastasiadis AG, Sachdev R, Salomon L, et al. Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer. J Cancer Res Clin Oncol. 2003;129:676–82.
36. Ismail M, Ahmed S, Kastner C, Davies J. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. BJU Int. 2007;100:760–4.